Vivakor, Inc. (OTCBB: VIVK) has completed a distribution agreement with Regeneca International, Inc. The exclusive distribution agreement was for one of Regeneca's nutraceutical formulations.
As part of the agreement, Vivakor has made an immediate purchase order for 25,000 units of the product. The purchase represents a significant revenue stream for Vivakor's developing nutraceutical division.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
